Skip to main content
. 2022 Sep 28;14(19):4739. doi: 10.3390/cancers14194739
cDNA Complementary DNA
CI Confidence intervals
CT Computed tomography
Ct Cycle threshold
DCR Disease Control Rate
ECOG Eastern Cooperative Oncology Group
EDTA Ethylenediaminetetraacetic acid
EMT Epithelial to Mesenchymal Transition
HR Hazard ratio
ICIs Immune Checkpoint Inhibitors
MDSCs Myeloid-Derived Suppressor Cells
miRNAs microRNAs
MRI Magnetic resonance imaging
NK Natural killer cells
non-SqCC non-Squamous
NSCLC Non-Small Cell Lung Cancer
ORR Objective Response Rate
OS Overall survival
PD Progression disease
PDDC Prolonged Duration of Disease Control
PFS Progression-free survival
PR Partial response
PS Performance status
RT-qPCR Real-time quantitative polymerase chain reaction
SD Stable disease
SqCC Squamous
TILs Tumor-infiltrating lymphocytes
TME Tumor microenvironment
TNBC Triple-negative breast cancer
Tregs T regulatory cells